Transgene Biotek Ltd Share Price
(526139)
Check the latest share price of Transgene Biotek Ltd, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.
as on 04:01PM, 12 May 2025
BSE
Get real-time share price information, day’s high and low, historical returns and market stats.
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -4.57 % |
3 Month Return | -19.86 % |
1 Year Return | -47.41 % |
3 Year Return | -0.56 % |
5 Year Return | + 2.01 % |
Market Stats | |
Previous Close | ₹3.55 |
Open | ₹3.72 |
Volume | 47.20K |
Upper Circuit | ₹3.72 |
Lower Circuit | ₹3.38 |
Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.
Market Cap
₹26.90 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
-44.38
Return on capital employed (ROCE)
0Industry PE ratio
100.56
Beta (LTM)
0.28
P/B Ratio
-8.95
Dividend Yield
0PEG Ratio
-2218.75
Quarterly Earnings Growth YOY
162.96
EPS (TTM)
-0.09
Sector
Healthcare
Book Value
1.41
Technical Analysis
Bearish
View Technical Analysis
Investing in Transgene Biotek Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Transgene Biotek Ltd or 526139 on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Transgene Biotek Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Transgene Biotek Ltd with just a few clicks!
Track how the P/E of Transgene Biotek Ltd has moved over time to understand valuation trends.
Transgene Biotek Ltd in the last 5 years
Lowest (-227.67x)
December 31, 2024
Today (-44.38x)
May 9, 2025
Industry (100.56x)
May 9, 2025
Highest (13.23x)
October 8, 2018
Today’s Price to Earnings Ratio: -44.38x
Get the annual and quarterly financial summary of Transgene Biotek Ltd, including revenue, profit, loss and more.
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Transgene Biotek Ltd.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 21.68% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 70.04% | 0.00 | |
Others | 8.28% | 0.00 |
Compare market cap, revenue, PE, and other key metrics of Transgene Biotek Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 26.90 | 0.4% | 1.11 | -1 | NA | |
BUY | 3,475.32 | 179.53% | 0.56 | 123 | 1,244 | |
NA | 43.25 | -0.04% | 0.60 | 1 | 12 | |
BUY | 10,192.81 | 12.03% | 0.64 | 119 | 547 | |
NA | 152.52 | 40.61% | 0.51 | 2 | 48 |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 3 quarters, 0.1 Cr → 0.12 Cr (in ₹), with an average increase of 8.3% per quarter
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 70.04% of holdings in Mar 2025 quarter
Against Peers
In the last 1 year, Vimta Labs Ltd has given 95.2% return, outperforming this stock by 142.6%
Against Peers
In the last 3 years, Vimta Labs Ltd has given 180.6% return, outperforming this stock by 181.2%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 21.68% of holdings in Mar 2025 quarter
Price Dip
In the last 6 months, Transgene Biotek stock has moved down by -49.6%
Profit Down
Netprofit is down for the last 4 quarters, 0.2 Cr → -0.71 Cr (in ₹), with an average decrease of 284.2% per quarter
Organisation | Transgene Biotek Ltd |
Industry | Healthcare |
CEO | K Koteswara Rao |
E-voting on shares | Click here to vote |
Transgene Biotek Ltd share price today stands at ₹3.49, Open: ₹3.72, Previous Close: ₹3.55, High: ₹3.72, Low: ₹3.4, 52 Week High: ₹10.84, 52 Week Low: ₹3.22.
Today's traded volume of Transgene Biotek Ltd(526139) is 47.20K.
Today's market capitalisation of Transgene Biotek Ltd(526139) is ₹26.90 Cr.
Transgene Biotek Ltd (526139) share price is ₹3.49. It is down -67.80% from its 52 Week High price of ₹10.84
Transgene Biotek Ltd (526139) share price is ₹3.49. It is up 8.39% from its 52 Week Low price of ₹3.22